Remove Drug Development Remove Pharma R&D Remove Research Remove Treatment
article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

Significantly for drug discovery, ‘scientific research and development’ is excluded from the scope of the Act, though this will be defined further in future guidance. This would ensure that rules enable, rather than hinder, the development of safe and effective treatments that reach patients faster and more efficiently.”

article thumbnail

Rethinking the pharma R&D lifecycle with AI in mind

Drug Discovery World

Even though millions of people are needed to participate in clinical trials, fewer than 5% of Americans 6 have participated in clinical research of any kind. If the bulk of biopharma R&D continues to operate as it does today, a treasure trove of new drugs will be created that may never make their way to patients.